Unlike B16F10 melanoma cells, breast cancer (BC) and other hormone-sensitive malignancies rely on estrogen receptor (ER) signaling as a crucial control mechanism for cell division, population growth, and survival. This evidence concerns the gene ESR1 and melanoma.